Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP).
Phase of Trial: Phase IV
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Hydrochlorothiazide; Valsartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 10 Jun 2017 Biomarkers information updated
- 07 Nov 2011 Actual patient number is 1677 according to ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (June 2005) added as reported by ClinicalTrials.gov.